Entrada Therapeutics: 4 Jobs & Salaries (2026)

Visa sponsorship

United States · H-1B filings in 12 months: 7 · green card filings: 1

Overview

Headquartered in Boston’s Seaport community, Entrada Therapeutics is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of genetic medicines that engage intracellular targets that have long been considered inaccessible. Through proprietary, versatile and modular approaches, we are advancing a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases, among others. Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne muscular dystrophy who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1. For more information about Entrada, please visit our website, www.entradatx.com

News

News markets.businessinsider.com 1 month ago

Entrada Therapeutics Announces Recipients of Fourth Annual DREAMS Grant Program

-- Announced following World Duchenne Awareness Day on September 7, grants are designed to support projects bridging healthcare disparities across...

Tech stack

Technologies named in job postings at Entrada Therapeutics over the last 12 months, by layer, with the share of postings for each.

Technologies in use

6

Postings analysed

10

Stack modernity

64/100

Languages

Python20%

SAS20%

MATLAB10%

Cloud & platforms

GCP60%

Practices & domains

GMP10%

Machine Learning10%

Sign in to see how your skills match this stack Sign In

Salary insights

Compensation ranges based on this company's open jobs

Median

$208k

Typical range

$167k – $250k

Open positions

2

2 Jobs

Senior 50%

Architect 50%

Level	Jobs	Median	Typical range
Senior	1	$167k	$167k
Architect	1	$250k	$250k

Highest paying role Director, Regulatory Writing $250k

Normalized to USD per year

People

Dipal Doshi

Executive Officer, Director

SEC Form D

Natarajan Sethuraman

Executive Officer

SEC Form D

Louis Tartaglia

Director

SEC Form D

Kush Parmar

Director

SEC Form D

Nathan Dowden

Executive Officer

SEC Form D

Mario Saltarelli

Executive Officer

SEC Form D

Nerissa Kreher

Executive Officer

SEC Form D

Kory Wentworth

Executive Officer

SEC Form D

Anja Harmeier

Director

SEC Form D

Dehua Pei

Director

SEC Form D

John Crowley

Director

SEC Form D

Christine Brennan

Director

SEC Form D

Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Growth

Hiring Momentum

56/100

Growing

Open positions

7

3 opened / 1 closed in 30 days

Median time-to-fill

43 days

faster than 30% of the market

ATS activity

Every ~5 hours

Today

Hiring Dynamics 0%

Hiring Focus

The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.

Early Careers

45% ▼

Biotech

27% ▲

Finance

9% ▲

Management

9% ▼

Science & Research

9% ▲

Activity Timeline

Added MATLAB to stack Oct 2026